Medical Developments International Limited
MVP
株式のランク
#27370
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
株価
$0.28211392
時価総額
$31.78M
変化（1日）
0.00%
変化（1年）
-12.00%
国
AU
取引 Medical Developments International Limited (MVP)
カテゴリー
Healthcare
の時価総額 Medical Developments International Limited(MVP)
時価総額: $31.78M
October 2026時点で、Medical Developments International Limited の時価総額は $31.78M です。これは、当社のデータによると、Medical Developments International Limited が世界で27370th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Medical Developments International Limited の時価総額の履歴（2020 から 2026 まで）
